Natural coumarins as a novel class of neuroprotective agents

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 11, 2009, Pages 1262-1271

  Epifano, Francesco ^a   Curini, Massimo ^b   Menghini, Luigi ^a   Genovese, Salvatore ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Chemoprevention; Coumarins; Natural compounds; Neurodegenerative disorders; Neuroprotective activity

Indexed keywords

7 ISOPENTENYLOXYCOUMARIN; ANGELICA GIGAS EXTRACT; CARBAMAZEPINE; COUMARIN DERIVATIVE; EPOXYANGELOYL DECURSINOL; FRAXETIN; FRAXETIN 8; LAMOTRIGINE; MARMESIN; MYRICETIN; NODAKENETIN; PENTOSALEN; PHENOBARBITAL; PHENYTOIN; ROTENONE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; CHEMOPROPHYLAXIS; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; LIPID PEROXIDATION; MONOTHERAPY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PHARMACODYNAMICS; SEIZURE; SHORT SURVEY;

COUMARINS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PSORALENS;

EID: 73349137619     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709789878141     Document Type: Short Survey

References (42)

1. Armstrong, R.A.; Lantos, P.L.; Cairns, R.J. Overlap between neurodegenerative disorders. Neuropathology, 2005, 25, 111-124.
2. Minghetti, L. Role of Cox-2 in inflammatory and brain diseases. Subcell. Biochem., 2007, 42, 127-141.
3. Bortolato, M.; Chen, K.; Shi, J.C. Monoamine oxidase inactivation: From pathophysiology to therapeutics. Adv. Drug. Deliver. Rev., 2008, 60, 1527-1533.
4. Bustamante, J.; Czerniczyniec, A.; Lores-Arnaiz, S. Brain nitric oxide synthases and mitochondrial function. Front. Biosci., 2007, 12, 1034-1040.
5. Ribe, E.M.; Serrano-Saiz, E.; Akpan, N.; Troy, C.M. Mechanisms of neuronal death in disease: defining the models and the players. Biochem. J., 2008, 415, 165-182.
6. Hider, R.C.; Ma, Y.; Molina-Holgado, F.; Gaeta, A.; Roys, S. Iron chelation as a potential therapy for neurodegenerative disease. Biochem. Soc. Trans. 2008, 36, 1304-1308.
7. Valko, M.; Leibfritz, D.; Moncol,. J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol., 2007, 39, 44-84.
8. Yokoyama, H.; Kuroiwa, H.; Yano, R.; Araki, T. Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease. Neurol. Sci. 2008, 29, 293-301.
9. Orr. J.D. Statins in the spectrum of neurologic disease. Curr. Atheroscler. Rep., 2008, 10, 11-18.
10. Deutsch, S.I.; Rosse, R.B.; Mastropaolo, J.; Long, K.D., Gaskins, K.L. Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time?. Clin. Neuropharmacol., 2008, 31, 104-119.
11. Sugaya, K., Merchant, S. How to approach Alzheimer's disease therapy using stem cell technologies. J. Alzheimer. Dis., 2008, 15, 241-254.
12. Yan, J.J.; Cho, J.Y.; Kim, H.S.; Kim, K.L.; Jung, J.S.; Huh, S.O.; Suh, H.W.; Kim, Y.H.; Song, D.K. Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol., 2001, 133, 89-96.
13. Heo, H.J.; Park, Y.J.; Suh, Y.M.; Choi, S.J.; Kim, M.J.; Cho, H.Y.; Chang, Y.J.; Hong, B.; Kim, H.K.; Kim, E.; Kim, C.J.; Kim, B.G.; Shin, D.H.. Effects of oleamide on choline acetyltransferase and cognitive activities. Biosci. Biotech. Biochem., 2003, 67, 1284-1291.
14. Heo, H.J.; Kim, D.O.; Shin, S.C.; Kim, M.J.; Kim, B.G.; Shin, D.H. Effect of antioxidant flavanone, naringenin, from Citrus junos on neuroprotection. J. Agric. Food Chem., 2004, 52, 1520-1525.
15. Heo, H.J.; Kim, D.O.; Choi, S.J.; Shin, D.H.; Lee, C.Y. Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid β-protein- induced neurotoxicity. J. Agric. Food Chem., 2004, 52, 4128-4132.
16. Zaveri, N.T. Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Sci., 2006, 78, 2073-2080.
17. Bruno, R.S. Handbook of Nutraceuticals and Functional Foods 2nd ed. Publisher: CRC Press LLC, Boca Raton, Fla. 2007, pp. 309-333.
18. Goel, A.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin as "Curecumin": From kitchen to clinic. Biochem. Pharmacol., 2008, 75, 787-809.
19. Macreadie, I.; Lotfi-Miri, M.; Mohotti, S.; Shapira, D.; Bennett, L.; Varghese, J. Validation of folate in a convenient yeast assay suited for identification of inhibitors of Alzheimer's amyloid-β aggregation. J Alzheimer Dis., 2008, 15, 391-396.
20. Murray, R.D.H. Progress in the Chemistry of Organic Natural Products: The Naturally Occurring Coumarins, Springer-Verlag: Wien, New York, 2002.
21. Egan, D.; O'Kennedy, E.; Moran, E.; Cox, D.; Prosser, E.; Thornes, R.D. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab. Rev., 1990, 22, 503-529.
22. Neichi, T.; Koshihara, Y.; Mutora, S.I. Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim. Biophys. Acta, 1983, 753, 130-132.
23. Kimura, Y.; Okuda, H; Arichi, S.; Baba, K.; Kozawa, M. Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Biochim. Biophys. Acta, 1985, 834, 224-229
24. Craven, P.A.; Pfanstiel, J.; De Rubertis, F.R.. Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation. J. Clin. Invest., 1986, 77, 850-859.
25. Ozaki, Y.; Ohashi, T.; Niwa, Y. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Biochem. Pharmacol., 1986, 35, 3481-3488.
26. Paya, M.; Halliwell, B.; Hoult, J.R.S. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem. Pharmacol., 1992, 44, 205-214.
27. Mora, A.; Paya, M.; Rios, J.L.; Alcaraz, M.J. Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem. Pharmacol., 1990, 40, 793-797.
28. Liu, R.; Sun, Q.; Sun, A.; Cui, J. Isolation and purification of coumarin compounds from Cortex fraxinus by high-speed counter-current chromatography. J. Chromatogr. A, 2005, 1072,195-199.
29. Yanishlieva, N.V.; Marinova, E.M. Antioxidative effectiveness of some natural antioxidants in sunflower oil. Z. Lebensm. Unters Forsch., 1996, 203, 220-223.
30. Curini, M.; Cravotto, G.; Epifano, F.; Giannone, G. Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Curr. Med. Chem., 2006, 13, 199-222.
31. Kang, S.Y.; Kim, Y.C. Neuroprotective coumarins from the root of Angelica gigas : Structure-activity relationships. Arch. Pharm. Res., 2007, 30, 1369-1373.
32. Martín-Aragón, S.; Benedí, J.M.; Villar, A.M. Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment. J. Pharm. Pharmacol., 1997, 49, 49-52.
33. Molina-Jimenez, M.F.; Sanchez-Reus, M.I.; Benedi, J. Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SHSY5Y cells: comparison with N-acetylcysteine. Eur. J. Pharmacol., 2003, 472, 81-87.
34. Molina-Jimenez, M.F.; Sanchez-Reus, M.I.; Andres, D.; Cascales, M.; Benedi, J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res., 2004, 1009, 9-16.
35. Molina-Jimenez, M.F.; Sanchez-Reus, M.I.; Cascales, M.; Andres, D.; Benedi, J. Effect of fraxetin on antioxidant defense and stress proteins in human neuroblastoma cell model of rotenone neurotoxicity. Comparative study with myricetin and N-acetylcysteine. Toxicol. Appl. Pharmacol., 2005, 209, 214-225.
36. Sanchez-Reus, M.I.; Peinado, I.I.; Molina-Jimenez, M.F.; Benedi, J. Fraxetin prevents rotenone-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells. Neurosci. Res., 2005, 53, 48-56.
37. Choi, S.Y.; Ahn, E.M.; Song, M.C.; Kim, D.W.; Kang, J.H.; Kwon, O.S.; Kang, T.C.; Baek, N.I. In vitro GABA-transaminase inhibitory compounds from the root of Angelica dahurica. Phytother. Res., 2005, 19, 839-845.
38. Luszczki, J.J.; Glowniak, K.; Czuczwar, S.J. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice. Eur. J. Pharmacol., 2007, 574, 133-139.
39. Luszczki, J.J.; Wojda, E.; Raszewski, G.; Glowniak, K.; Czuczwar, S.J. Influence of imperatorin on the anticonvulsant activity and acute adverse-effect profile of lamotrigine in maximal electroshock-induced seizures and chimney test in mice. Pharmacol. Rep., 2008, 60, 566-573.
40. Epifano, F.; Molinaro, G.; Genovese, S.; Teke Ngomba, R.; Nicoletti, F.; Curini, M. Neuroprotective effect of prenyloxycoumarins from edible vegetables. Neurosci. Lett., 2008, 443, 57-60.
41. Kang, S.Y.; Lee, K.Y.; Sung, S.H.; Kim, Y.C. Four New Neuroprotective Dihydropyranocoumarins from Angelica gigas. J. Nat. Prod., 2005, 68, 56-59.
42. Kontogiorgis, C.A.; Xu, Y.; Hadjipavlou-Litina, D.; Luo, Y. Coumarin derivatives protection against ROS production in cellular models of Abeta toxicities. Free Radic. Res., 2007, 41, 1168-1180.